We are live on ! Find out more
DYN icon

Dyne Therapeutics

193 hedge funds and large institutions have $3.92B invested in Dyne Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $973K

124% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 21

72% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 46

45% more capital invested

Capital invested by funds: $2.71B → $3.92B (+$1.21B)

40% more funds holding in top 10

Funds holding in top 10: 1014 (+4)

14% more funds holding

Funds holding: 169193 (+24)

3.01% less ownership

Funds ownership: 116.41%113.4% (-3%)

Holders
193
Holders Change
+24
Holders Change %
+14.2%
% of All Funds
2.79%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.2%
New
47
Increased
79
Reduced
46
Closed
21
Calls
$6.11M
Puts
$973K
Net Calls
+$5.13M
Net Calls Change
+$11.2M
Name Holding Trade Value Shares
Change
Change in
Stake
DekaBank Deutsche Girozentrale
101
DekaBank Deutsche Girozentrale
Germany
$1.71M
Tudor Investment Corp
102
Tudor Investment Corp
Connecticut
$1.66M -$287K -9,892 -17%
MIM
103
MetLife Investment Management
New Jersey
$1.65M +$472K +16,237 +53%
Squarepoint
104
Squarepoint
New York
$1.59M -$988K -33,984 -43%
CF
105
Corebridge Financial
Texas
$1.53M +$1.26M +43,414 New
Mirae Asset Global ETFs Holdings
106
Mirae Asset Global ETFs Holdings
Hong Kong
$1.4M +$1.15M +39,640 New
RJFSA
107
Raymond James Financial Services Advisors
Florida
$1.37M +$229K +7,884 +26%
OC
108
Oppenheimer & Co
New York
$1.36M +$288K +9,926 +35%
Citigroup
109
Citigroup
New York
$1.3M -$7.65M -263,414 -88%
AIM
110
Arcadia Investment Management
Michigan
$1.24M +$112K +3,850 +12%
CCM
111
Cinctive Capital Management
New York
$1.22M +$1M +34,529 New
Deutsche Bank
112
Deutsche Bank
Germany
$1.2M +$202K +6,962 +26%
New York State Common Retirement Fund
113
New York State Common Retirement Fund
New York
$1.17M +$387K +13,330 +67%
UOC
114
UBS O'Connor
Illinois
$1.16M -$5.26K -181 -0.5%
First Trust Advisors
115
First Trust Advisors
Illinois
$982K +$808K +27,821 New
VCM
116
Virtue Capital Management
Tennessee
$975K +$646K +22,227 New
PA
117
Profund Advisors
Maryland
$968K -$756K -26,026 -49%
Wells Fargo
118
Wells Fargo
California
$920K +$177K +6,103 +31%
Ameriprise
119
Ameriprise
Minnesota
$919K +$756K +26,028 New
Susquehanna International Group
120
Susquehanna International Group
Pennsylvania
$901K -$12.1M -415,013 -94%
Alyeska Investment Group
121
Alyeska Investment Group
Illinois
$882K +$726K +25,000 New
CCIA
122
Campbell & Co Investment Adviser
Maryland
$881K -$372K -12,801 -34%
OAC
123
OMERS Administration Corp
Ontario, Canada
$833K +$686K +23,600 New
State Board of Administration of Florida Retirement System
124
State Board of Administration of Florida Retirement System
Florida
$727K +$599K +20,605 New
AA
125
AlphaCentric Advisors
Puerto Rico
$706K

DYN Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2024, worth a combined $3.92B — up 45% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new DYN positions and 21 closed out — a net gain of 26 holders — while 79 added to existing stakes and 46 trimmed.

The largest buyer was RTW Investments, adding an estimated $95.8M. The largest seller was MPM Asset Management, cutting an estimated $54.9M.

  • 193 institutional investors held Dyne Therapeutics (DYN) as of Q2 2024, up from 169 in Q1 2024.
  • Funds reported $3.92B of Dyne Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
  • 47 funds opened new Dyne Therapeutics positions in Q2 2024 and 21 closed out, a net change of +26 holders.
  • The largest Dyne Therapeutics buyer in Q2 2024 was RTW Investments, an estimated $95.8M added.
  • The largest Dyne Therapeutics seller in Q2 2024 was MPM Asset Management, an estimated $54.9M sold.

Based on aggregated 13F filings for Q2 2024.